BlackRock »

Intra Cellular Therapies shares owned by BlackRock

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $455M 6.2M 73.17

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Perceptive Advisors
Geode Capital Management
Pictet Asset Management Holding SA
Suvretta Capital Management
Deep Track Capital

View all funds holding Intra Cellular Therapies